Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs SCHLX overlap: 72% of top holdings shared

Bottom line

How much do PRHSX and SCHLX overlap?

72% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 55.6% of PRHSX's assets and 59.7% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.

PRHSX holds far more positions (279 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXSCHLX
Weight overlap (top 25)72%
Shared holdings15
Weight in shared holdings55.6%59.7%
Total positions27965
Expense ratio0.83%1.06%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PRHSX and SCHLX have in common

Holding% of PRHSX% of SCHLXOverlap
Eli Lilly & Co14.28%13.85%13.85%
Johnson & Johnson6.63%6.19%6.19%
Unitedhealth Group Inc5.99%5.73%5.73%
Abbvie Inc5.10%4.90%4.90%
Merck & Co. Inc.4.01%4.85%4.01%
Gilead Sciences Inc2.82%2.78%2.78%
Thermo Fisher Scientific Inc2.52%3.46%2.52%
Vertex Pharmaceuticals Inc2.28%2.45%2.28%
Bristol-myers Squibb Co2.11%1.50%1.50%
Abbott Laboratories1.89%2.39%1.89%
Intuitive Surgical Inc1.87%2.69%1.87%
Amgen Inc1.82%2.88%1.82%
Stryker Corp1.78%2.61%1.78%
Danaher Corp1.43%2.13%1.43%
Cardinal Health Inc1.03%1.34%1.03%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Elevance Health Inc — 1.53%
  2. Natera Inc — 1.44%
  3. Guardant Health Inc — 1.23%
  4. Royalty Pharma Plc- Cl A — 0.97%
  5. Cvs Health Corp — 0.94%
  6. Tenet Healthcare Corp — 0.94%
  7. Kymera Therapeutics Inc — 0.89%
  8. Protagonist Therapeutics Inc — 0.85%
  9. Moderna Therapeutics Inc — 0.83%
  10. Brightspring Health Services — 0.82%

Only in SCHLX

  1. AstraZeneca PLC — 3.80%
  2. Novartis AG — 2.90%
  3. Boston Scientific Corp — 2.10%
  4. McKesson Corp — 2.05%
  5. Novo Nordisk A/S — 1.73%
  6. Medtronic PLC — 1.54%
  7. Regeneron Pharmaceuticals Inc — 1.43%
  8. Cencora Inc — 1.26%
  9. Roche Holding AG — 1.24%
  10. Pfizer Inc — 1.17%

Asset mix

Asset typePRHSXSCHLX
Stocks96.4%99.6%
Preferred stock3.0%—
Cash & short-term funds0.7%0.5%
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPRHSXSCHLX
US92.6%85.7%
CH0.5%5.2%
GB1.7%3.8%
DK0.7%1.7%
IE0.8%1.5%
FR0.2%1.0%
NL1.0%1.0%
BM0.7%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PRHSX and SCHLX overlap?
About 72% by weight. 15 securities appear in both funds' top 25 holdings; they make up 55.6% of PRHSX's assets and 59.7% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do PRHSX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Abbvie Inc, Merck & Co. Inc..
Should I own both PRHSX and SCHLX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, PRHSX or SCHLX?
PRHSX is broader, with 279 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.